China Healthwise Holdings Limited, an investment holding company, engages in the sale of Chinese health products in Hong Kong. It operates through three segments: Chinese Health Products, Money Lending Business, and Investment in Financial Instruments. The company sells Chinese and other pharmaceutical products, health products, ginseng, and dried seafood products to wholesalers and retailers; and trades and retails Sum Yung and dried seafood under the Nam Pei Hong brand name. It is also involved in money lending business; and invests in financial instruments. The company was formerly known as Haier Healthwise Holdings Limited and changed its name to China Healthwise Holdings Limited in January 2017. China Healthwise Holdings Limited was incorporated in 1997 and is headquartered in Central, Hong Kong.
Frequently asked questions
What sector does China Healthwise Holdings Ltd (0348) operate in?
China Healthwise Holdings Ltd belongs to the Consumer Discretionary sector and operates in the Pharmaceutical Retailers industry.
What is China Healthwise Holdings Ltd (0348) current stock price?
As of the latest data, China Healthwise Holdings Ltd stock price is HK$0.07, with a previous close of HK$0.07. China Healthwise Holdings Ltd gained HK$0.00 in the last trading session, representing a 2.86% increase.
What is China Healthwise Holdings Ltd (0348) current market capitalization?
China Healthwise Holdings Ltd market cap is approximately 66.57 million.
What is China Healthwise Holdings Ltd (0348) EBITDA?
China Healthwise Holdings Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -13.85 million.
Does China Healthwise Holdings Ltd (0348) pay dividends?
No. China Healthwise Holdings Ltd does not pay a dividend.
What is China Healthwise Holdings Ltd (0348) beta (volatility) score?
China Healthwise Holdings Ltd has a beta of -0.466, indicating lower volatility than the overall market.
